These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38576317)

  • 21. HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.
    Zhou J; Price AJ; Halambage UD; James LC; Aiken C
    J Virol; 2015 Sep; 89(17):9068-79. PubMed ID: 26109731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor.
    Shi J; Zhou J; Halambage UD; Shah VB; Burse MJ; Wu H; Blair WS; Butler SL; Aiken C
    J Virol; 2015 Jan; 89(1):208-19. PubMed ID: 25320302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.
    Sun L; Dick A; Meuser ME; Huang T; Zalloum WA; Chen CH; Cherukupalli S; Xu S; Ding X; Gao P; Kang D; De Clercq E; Pannecouque C; Cocklin S; Lee KH; Liu X; Zhan P
    J Med Chem; 2020 May; 63(9):4790-4810. PubMed ID: 32298111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel PF74-like small molecules targeting the HIV-1 capsid protein: Balance of potency and metabolic stability.
    Wang L; Casey MC; Vernekar SKV; Sahani RL; Kirby KA; Du H; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Acta Pharm Sin B; 2021 Mar; 11(3):810-822. PubMed ID: 33777683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz.
    Twizerimana AP; Scheck R; Becker D; Zhang Z; Wammers M; Avelar L; Pflieger M; Häussinger D; Kurz T; Gohlke H; Münk C
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulators.
    Zhang X; Sun L; Xu S; Huang T; Zhao F; Ding D; Liu C; Jiang X; Tao Y; Kang D; De Clercq E; Pannecouque C; Cocklin S; Dick A; Liu X; Zhan P
    RSC Med Chem; 2023 Jul; 14(7):1272-1295. PubMed ID: 37484571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
    Hulme AE; Kelley Z; Foley D; Hope TJ
    J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of HIV-1 capsid recognition by PF74 and CPSF6.
    Bhattacharya A; Alam SL; Fricke T; Zadrozny K; Sedzicki J; Taylor AB; Demeler B; Pornillos O; Ganser-Pornillos BK; Diaz-Griffero F; Ivanov DN; Yeager M
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18625-30. PubMed ID: 25518861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The discovery and design of novel HIV-1 capsid modulators and future perspectives.
    Ding D; Xu S; Zhang X; Jiang X; Cocklin S; Dick A; Zhan P; Liu X
    Expert Opin Drug Discov; 2023 Jan; 18(1):5-12. PubMed ID: 36480372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly.
    Price AJ; Jacques DA; McEwan WA; Fletcher AJ; Essig S; Chin JW; Halambage UD; Aiken C; James LC
    PLoS Pathog; 2014 Oct; 10(10):e1004459. PubMed ID: 25356722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Small Molecule, ACAi-028, with Anti-HIV-1 Activity Targets a Novel Hydrophobic Pocket on HIV-1 Capsid.
    Chia T; Nakamura T; Amano M; Takamune N; Matsuoka M; Nakata H
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0103921. PubMed ID: 34228546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Pseudosubstrate Envelope"/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand Efficiency.
    Xu S; Wang S; Zhou Y; Foley N; Sun L; Walsham L; Tang K; Shi D; Shi X; Zhang Z; Jiang X; Gao S; Liu X; Pannecouque C; Goldstone DC; Dick A; Zhan P
    J Med Chem; 2024 Oct; ():. PubMed ID: 39418501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional label-free assays for characterizing the in vitro mechanism of action of small molecule modulators of capsid assembly.
    Lad L; Clancy S; Koditek D; Wong MH; Jin D; Niedziela-Majka A; Papalia GA; Hung M; Yant S; Somoza JR; Hu E; Chou C; Tse W; Halcomb R; Sakowicz R; Pagratis N
    Biochemistry; 2015 Apr; 54(13):2240-8. PubMed ID: 25774576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Off-Pathway Assembly: A Broad-Spectrum Mechanism of Action for Drugs That Undermine Controlled HIV-1 Viral Capsid Formation.
    Pak AJ; Grime JMA; Yu A; Voth GA
    J Am Chem Soc; 2019 Jul; 141(26):10214-10224. PubMed ID: 31244184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PF74 and Its Novel Derivatives Stabilize Hexameric Lattice of HIV-1 Mature-Like Particles.
    Dostálková A; Škach K; Kaufman F; Křížová I; Hadravová R; Flegel M; Ruml T; Hrabal R; Rumlová M
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32325987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 CA Inhibitors Are Antagonized by Inositol Phosphate Stabilization of the Viral Capsid in Cells.
    Sowd GA; Shi J; Aiken C
    J Virol; 2021 Nov; 95(24):e0144521. PubMed ID: 34613803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors.
    Jiang X; Wu G; Zalloum WA; Meuser ME; Dick A; Sun L; Chen CH; Kang D; Jing L; Jia R; Cocklin S; Lee KH; Liu X; Zhan P
    RSC Adv; 2019; 9(50):28961-28986. PubMed ID: 32089839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 capsid stability enables inositol phosphate-independent infection of target cells and promotes integration into genes.
    Sowd GA; Shi J; Fulmer A; Aiken C
    PLoS Pathog; 2023 Jun; 19(6):e1011423. PubMed ID: 37267431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors.
    Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H
    Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based virtual screening workflow to identify antivirals targeting HIV-1 capsid.
    Sun Q; Biswas A; Vijayan RSK; Craveur P; Forli S; Olson AJ; Castaner AE; Kirby KA; Sarafianos SG; Deng N; Levy R
    J Comput Aided Mol Des; 2022 Mar; 36(3):193-203. PubMed ID: 35262811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.